We demonstrated that JQ1 prevented BRD4 binding to the MYC promoter and enhancer, thereby inhibiting MYC expression and, consequently, the growth of bladder tumor cells expressing activated forms of FGFR3 both in vitro and in vivo in xenograft. Here, BRD4 is linked to urinary bladder neoplasm.